Category: us corporate news

us corporate news

DeFi Development Corp: Solana Blockchain Treasury, AI Real Estate Platform, and Risk Management Overview

Minichart

March 31, 2026

DeFi Development Corp. 2025 Annual Report: Key Points for In...

Continue Reading 0

us corporate news

Key Business Risks, Intellectual Property Challenges, and Regulatory Issues for Pharmaceutical Companies in 2025 Annual Report

Minichart

March 31, 2026

TherapeuticsMD, Inc. Annual Report Analysis: Key Investor In...

Continue Reading 0

us corporate news

Haymaker Acquisition Corp. 4 2025 Annual Report: Suncrete Business Combination, Strategy, and Risk Factors Explained

Minichart

March 31, 2026

HYAC 2025 Annual Report: Key Investor Highlights HYA...

Continue Reading 0

us corporate news

Laird Superfood, Inc. 2025 Annual Report: Growth Strategy, Product Portfolio, Market Opportunity, and Distribution Channels

Minichart

March 31, 2026

Laird Superfood, Inc. 2025 Annual Report: Key Highlights and...

Continue Reading 0

us corporate news

Applied Energetics, Inc. Advances Ultrashort Pulse Laser and Photonics Technology for Defense and Commercial Markets 161718

Minichart

March 31, 2026

Applied Energetics, Inc. 2025 Annual Report: Key Highlights ...

Continue Reading 0

us corporate news

Hennessy Capital Investment Corp. VIII: SPAC Business Overview, Competitive Strengths, and Initial Business Combination Strategy

Minichart

March 31, 2026

Hennessy Capital Investment Corp. VIII (HCICU) 10-K Report: ...

Continue Reading 0

us corporate news

Aspire Biopharma: Disruptive Sublingual Drug Delivery Technology, Pipeline, and Patent Portfolio Overview 798289

Minichart

March 31, 2026

Aspire Biopharma Holdings, Inc. 2025 Annual Report: Key High...

Continue Reading 0

us corporate news

OneMedNet Corp (ONMD) 2025 Annual Report: Nasdaq Listing, Financial Overview, and Key Company Information

Minichart

March 31, 2026

OneMedNet Corp Files Annual Report: Key Highlights for Inves...

Continue Reading 0

us corporate news

Helio Corporation Q1 2026 Financial Results: Revenue, Convertible Notes, and Derivative Liabilities Overview

Minichart

March 30, 2026

Helio Corporation Q1 2026 Financial Highlights and Analysis ...

Continue Reading 0

us corporate news

Neumora Therapeutics Reports Strong 2025 Financials and Clinical Pipeline Progress Including NMRA-511 Alzheimer’s Agitation Data and KOASTAL-2/3 Enrollment 123

Minichart

March 30, 2026

Neumora Therapeutics Reports Q4 and Full Year 2025 Financial...

Continue Reading 0